|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Actavis (Актавис)
Main Activities: Pharmaceutical and Medicine Manufacturing - Management of Companies and Enterprises
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Actavis EAD (Актавис EАД) Headquarters 29, Atanas Dukov Str.; Sofia; Sofia - city; 1407 |
Status: Non-Listed Legal Form: Joint Stock Company Operational Status: Operational BG VAT Identification Code: BG831042432 BULSTAT: 831042432 Financial Auditors: KPMG (2011) Incorporation Date: January 1, 1993 Total Employees: 300 Tel: (+359 2) 932 18 61 |
|
Company Description |
|
Bulgaria's largest pharmaceuticals group Actavis AD, former Balkanpharma Holding, is active in the development, manufacture and sale of generic pharmaceuticals, diagnostics and other healthcare products. It produces some 300 pharmaceutical products and is one of the largest companies within the Icelandic generic drug group Actavis, former Pharmaco. In December 2000, Pharmaco acquired Balkanpharma Holding, which owned controlling interests in three local drug plants - Balkanpharma-Dupnitsa, |
||
|
||
Company Analysis |
| According to the Individual - Audited financial statement for the Year of 2010, total net operating revenues decreased with -0.23%, from BGN 105,555 thousands to BGN 105,312 thousands. Operating result decreased from BGN 3,862 thousands to BGN 441 thousands which means -88.58% change. The results of the period reached BGN -33 thousands at the end of the period against BGN 2,369 thousands last year. Return on equity (Net income/Total equity) went from 19.08% to -0.27%, the Return On Asset (Net income / Total Asset) went from 1.96% to -0.03% and the Net Profit Margin (Net Income/Net Sales) went from 2.24% to -0.03% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 893.47% compared to 872.28% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 0.92 to 0.91 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2010 Y (non-cons) |
2009 Y (non-cons) |
|
 | ||
| Audited | Audited | |
| ||
| ISI Financial Statements | ISI Financial Statements | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
122,991 |
120,689 |
| ||
Current Assets |
XX,XXX |
XX,XXX |
| ||
Total Liabilities |
XXX,XXX |
XXX,XXX |
| ||
Shareholders Equity |
XX,XXX |
XX,XXX |
| ||
Current Liabilities |
XXX,XXX |
XXX,XXX |
| ||
| * All the accounts are in BGN. | ||
Income Statement
| ||
Total Operating Revenue |
XXX,XXX |
XXX,XXX |
| ||
Operational Profit (Loss) |
XXX |
X,XXX |
| ||
Net Profit (Loss) |
-XX |
X,XXX |
| ||
| * All the accounts are in BGN. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
-X.XX% |
X.XX% |
| ||
Annualised Return on Assets (ROA) |
-X.XX% |
X.XX% |
| ||
Return on Equity (ROE) |
-X.XX% |
XX.XX% |
| ||
Annualised Return on Equity (ROE) |
-X.XX% |
XX.XX% |
| ||
Return on Sales (ROS) |
-X.XX% |
X.XX% |
| ||
Return on Capital |
-X.XX% |
XX.XX% |
| ||
Gross Profit Margin |
XX.XX% |
XX.X% |
| ||
Operating Profit Margin |
-X.XX% |
-X.XX% |
| Efficiency Ratios | ||
| ||
Inventory Turnover |
X.XXx |
X.XXx |
| ||
Current asset turnover |
X.XXx |
X.XXx |
| ||
Fixed-asset turnover |
X.XXx |
X.XXx |
| ||
Asset Turnover |
X.XXx |
X.XXx |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
XXX |
X,XXX |
| ||
EBITDA |
XXX |
X,XXX |
| ||
Bookvalue (BV) |
XX,XXX |
XX,XXX |
| ||
Net Cash |
-XXX,XXX |
-XXX,XXX |
| Liquidity Ratios | ||
| ||
Current Ratio |
XX.XX% |
XX.XX% |
| ||
Quick ratio |
XX.XX% |
XX.XX% |
| ||
Doom's day ratio |
X.XX% |
X.XX% |
| Leverage Ratios | ||
| ||
Leverage ratio |
XXX.XX% |
XXX.XX% |
| ||
Debt to equity |
XXX.XX% |
XXX.XX% |
| ||
Debt to total assets |
XX.XX% |
XX.XX% |
| ||
Long Term Debt to Capital |
X.XX% |
X.XX% |
| Trend Ratios | ||
| ||
Revenue Trend |
XX.XX% |
|
| ||
Net Income Trend |
-X.XX% |
|
| ||
Operating Income Trend |
XX.XX% |
|
| ||
 |